Did regulators fail over selective serotonin reuptake inhibitors?

Healy, David 2006. Did regulators fail over selective serotonin reuptake inhibitors? British Medical Journal (BMJ) 333 (7558) , pp. 92-95. 10.1136/bmj.333.7558.92

Full text not available from this repository.

Abstract

Controversy over the safety of antidepressants has shaken public confidence. Were mistakes made and could they have been avoided? GlaxoSmithKline's recent letter to doctors points to a sixfold increase in risk of suicidal behaviour in adults taking paroxetine.1 This contrasts with the data in the UK Medicines and Healthcare Products Regulatory Authority's expert working group report on suicide and antidepressants published in December 2004.2 Many people expect drug companies to be slow to concede that a drug causes hazards, but we do not expect our regulators to be even slower, so any hint that this might have been the case needs to be examined.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	BMJ Publishing Group
ISSN:	0959-8138
Last Modified:	26 Nov 2015 11:20
URI:	https://orca.cardiff.ac.uk/id/eprint/82413

Citation Data

Cited 64 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item